Clinical Evaluation of Fitness to Drive in Patients with Brain Metastases

Overview

About this study

The purpose of this study is to determine whether neurologic examination in the outpatient setting is sufficient to predict suitability to drive in order to make recommendations of driving safety for patients with brain metastases.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adults ≥18 years old
  • Diagnosis of single or multiple brain metastases
  • Valid driver’s license

Exclusion Criteria: 

  • Other medical conditions that may preclude patients from driving (i.e. ocular pathology)
  • Additional neurological pathology that may impair driving 
    • History of stroke  
    • Dementia
    • Parkinson’s disease
    • History of seizures in the past 3 months

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Alyx Porter Umphrey, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Cancer-related trials contact form

Phone: 855-776-0015 (toll-free)

International patient clinical studies questions